Approaches to immune checkpoint inhibitor (ICI) maintenance therapy in metastatic urothelial cancer (mUC): A qualitative analysis of oncology providers in the United States.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback